Acute Erythroid Leukemia (M6): Outcome of Bone Marrow Transplantation

References

• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative group. Annals of Internal Medicine 1985; 103: 620–625
   PubMed Web of Science ®Google Scholar
• Villeval J, Cramer P, Lemoine F, Henri A, Bettaieb A, Ber-Naudin F, Beuzard Y, Berger R, Flandrin G, Breton-Gorius J, Vainchenker W. Phenotype of early erythroblastic leukemias. Blood 1986; 68: 1167–1174
   PubMed Web of Science ®Google Scholar
• Greaves M, Sieff C, Edwards P. Monoclonal antiglycophorin as a probe for erythroleukemias. Blood 1983; 80: 1105–1115
   Google Scholar
• Garand R, Duchayne E, Blancherd D, Robillard N, Kuhlein E, Fenneteau O, Salmon-Nguyen F, Grange M, Rousselot P, Demur C, Talmant P, Radford I, Flandrin G. and the Groupe Francais d'Hematologie Cellulaire. Minimally differentiated erythroleukaemia (AML M6 “variant”): A rare subset of AML distinct from AML M6. British Journal of Haematol-Ogy 1995; 90: 868–875
   PubMed Web of Science ®Google Scholar
• Fourth International Workshop on Chromosomes in Leukemia: Correlation between morphology and karytoype. Cancer Genetic Cytogenetic 1982; 11: 275
   Google Scholar
• Cardamone J, Kimmerle R, Marshall E. Development of acute erythroleukemia in B-cell immunoproloiferative disorders after prolonged therapy with alkylating drugs. The American Journal of Medicine 1974; 57: 836–842
   PubMed Web of Science ®Google Scholar
• Chabner B. Second neoplasm-a complication of cancer chemotherapy. New England Journal of Medicine 1977; 297: 213–215
   PubMed Web of Science ®Google Scholar
• Dameshek W, Gum F. Leukemia. Grune and Stratton, Inc, New York 1964
   Google Scholar
• Karle H, Killmann S-A, Jensen M, Nielson J. The vagaries of erythroleukaemia. Acta Medica Scandinavica 1974; 196: 245–253
   PubMedGoogle Scholar
• Roman C, Woessns S, Saez-Serrania J. Acute erythromy-elosis after benzene poisoning Acta Haematologic 1968; 40: 234–237
   PubMed Web of Science ®Google Scholar
• Fomi A, Moreo L. Chromosome studies in a case of benzene-induced erythroleukaemia. European Journal of Cancer 1969; 5: 459–463
   PubMed Web of Science ®Google Scholar
• Jandl J. Blood: Textbook of Hematology. Little. 1987; 647, Brown and Company
   Google Scholar
• Atkinson J, Hrisinko M, Weil S. Erythroleukemia: A review of 15 cases meeting the 1985 FAB criteria and survey of the literature. Blood Reviews 1993; 6: 204–214
   Web of Science ®Google Scholar
• Olopade O, Thangavelu M, Larson R, Mick R, Kowal-Vern A, Schumacher H, Le Beau M, Vardiman J, Rowley J. Clinical, morphological, and cytogenetic characteristics of 26 patients with acute erythroblastic leukeemia. Blood. 1992; 80: 2873–2882
   Google Scholar
• Goldberg S, Noel P, Klumpp T, Dewald G. The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease. American Journal of Clinical Oncology 1998; 21(1)42–7
   PubMed Web of Science ®Google Scholar
• Mehta J, Powles R, Singal S, Horton C, Hamblin M, Zomas A, Saso R, Prendiville J, Glynne P, Allford S, MacKay H, Treleaven J. Idarubicin, high-dose cytarabine. and etoposide for induction of remission in acute in leukemia. Seminars in Hematology 1996; 33%(4 Supp 3)18–23
   PubMed Web of Science ®Google Scholar
• Buccheri V, Matutes E, Dyer MJS, Catovsky D. Lineage commitment in biphenotypic leukemia. Leukemia 1993; 919–927
   PubMed Web of Science ®Google Scholar
• Reiffers J, Bernard P, Larme J, Dachary D, David B, Bois-Seau M, Broustet A. Acute erythroblastic leukemia presenting as acute undifferentiated leukemia: A report of two cases with ultrastructural features. Leukemia Research 1985; 9: 413–420
   PubMed Web of Science ®Google Scholar
• Breton-Gorius J, Villeval J, Mitjavila M, Vinci G, Guichard J, Rochant H, Flandrin G, Wainchenker W. Uleastructural and cytochemical characterization of blasts from early erythroblastic leukemias. Leukemia 1987; 1: 173–181
   PubMed Web of Science ®Google Scholar
• Cuneo A, Van Orshoven A, Michaux J, Boogaeris M, Lou-Wagie A, Doyen C, Dal Cin P, Fagioli F, Castoldi G, van den Berghe. Morphologic, immunologic and cytogenetic studies in erythroleukaemia: Evidence for multilineage involvement and identification of two distinct cytogenetic-clinicopatho-logical types. British Journal of Haematology 1990; 75: 346–354
   PubMed Web of Science ®Google Scholar
• Hann I, Stevens R, Goldstone A, Rees J, Wheatley K, Gray R, Burnett A. Randomizd comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukaemia. Results of the Medical Research Council's 10th AML trial. Blood 1997; 89: 2311–2318
   PubMed Web of Science ®Google Scholar
• Burnett A, Goldstone A, Stevens R, Hann I, Rees J, Gray R, Wheatley K. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. Lancet 1998; 351: 700–08
   PubMed Web of Science ®Google Scholar